No Medical Value? New Epilepsy Drug Derived from Marijuana Shows Promising Results
The Washington Post reported that a new drug based on cannabidiol (CBD), an extract of cannabis, showed promising results for treating epilepsy in a new study. According to an article in the Post,
Elizabeth Thiele, director of pediatric epilepsy at Massachusetts General Hospital and lead author of the study, said the results varied depending on the patient.
“For some, it does not do a whole lot. But for the people it does work in, it is priceless,” she said.
“One child who comes to mind had multiple seizures a day. She had been on every medication possible,” said Thiele, a professor of neurology at Harvard Medical School. Then the patient tried the cannabis-based treatment and has been seizure-free for almost four years. “She is now talking about college options. She would have never had that conversation before. It has been life-changing.”
It will be interesting to see how this affects the Federal government’s classification of marijuana as a Schedule 1 drug with no medical value.